首页|miRNA-21、白细胞介素-17、缺氧诱导因子-1α在多发性骨髓瘤患者中的表达水平及临床意义

miRNA-21、白细胞介素-17、缺氧诱导因子-1α在多发性骨髓瘤患者中的表达水平及临床意义

扫码查看
目的 探讨微小RNA-21(miRNA-21)、白细胞介素-17(IL-17)、缺氧诱导因子-1α(HIF-1α)在多发性骨髓瘤患者中的表达及临床意义.方法 选取78例多发性骨髓瘤患者和64例健康体检者,分别作为研究组和对照组.采用实时荧光定量聚合酶链反应(qPCR)检测两组受试者miRNA-21水平,酶联免疫吸附试验检测两组受试者血清IL-17、HIF-1α水平.比较两组受试者、不同预后情况多发性骨髓瘤患者miRNA-21、IL-17、HIF-1α水平.采用Pearson相关分析法分析多发性骨髓瘤患者miRNA-21与IL-17、HIF-1α水平的相关性.采用Cox风险比例回归模型分析多发性骨髓瘤患者预后的影响因素.采用受试者工作特征(ROC)曲线分析miRNA-21、IL-17、HIF-1α单独及联合检测对多发性骨髓瘤的诊断价值及对预后的预测价值.比较不同miRNA-21、IL-17、HIF-1α表达情况多发性骨髓瘤患者的生存情况.结果 研究组患者miRNA-21、IL-17、HIF-1α水平均明显高于对照组,差异均有统计学意义(P<0.01).预后不良多发性骨髓瘤患者miRNA-21、IL-17、HIF-1α水平均明显高于预后良好患者,差异均有统计学意义(P<0.01).多发性骨髓瘤患者miRNA-21与IL-17、HIF-1α水平均呈正相关(r=0.447、0.462,P<0.05).miRNA-21、IL-17、HIF-1α均是多发性骨髓瘤患者预后的独立危险因素(P<0.05).ROC曲线显示,miRNA-21、IL-17、HIF-1α联合检测诊断多发性骨髓瘤的曲线下面积(AUC)、灵敏度、特异度、阳性预测值、阴性预测值均高于三者单独检测;miRNA-21、IL-17、HIF-1α联合检测预测多发性骨髓瘤患者预后的AUC、灵敏度、阴性预测值均高于三者单独检测.miRNA-21、IL-17、HIF-1α高表达组多发性骨髓瘤患者的2年累积生存率分别低于miRNA-21、IL-17、HIF-1α低表达组患者,差异均有统计学意义(P<0.05).结论 多发性骨髓瘤患者中miR-NA-21、IL-17、HIF-1α 均高表达,且miRNA-21与IL-17、HIF-1α水平均呈正相关,三者联合检测可较好地诊断多发性骨髓瘤及预测预后,有助于临床及早采取有效的防治措施,改善多发性骨髓瘤患者的预后情况.
Expression levels and clinical significance of miRNA-21,interleukin-17 and hypoxia-inducible factor-1α in patients with multiple myeloma
Objective To investigate the expression levels and clinical significance of microRNA-21(miRNA-21),in-terleukin-17(IL-17)and hypoxia-inducible factor-1α(HIF-1α)in patients with multiple myeloma.Method A total of 78 multiple myeloma patients and 64 healthy subjects were selected as study group and control group,respectively.Real-time fluores cence quantitative polymerase chain reaction(qPCR)was used to detect miRNA-21 level,and enzyme linked immunosorbent assay was used to detect serum IL-17 and HIF-1α levels.The levels of miRNA-21,IL-17 and HIF-1α in two groups and multiple myeloma patients with different prognosis were compared.The correlation between miRNA-21 level and IL-17,HIF-1α levels in multiple myeloma patients was analyzed by Pearson correlation analysis.Cox propor-tional hazard regression model was used to analyze the prognostic factors of patients with multiple myeloma.The diag-nostic value and prognostic value of miRNA-21,IL-17 and HIF-1α single and combined detection in multiple myeloma were analyzed by receiver operating characteristic(ROC)curve.The survival of multiple myeloma patients with different expressions of miRNA-21,IL-17 and HIF-1α were compared.Result The levels of miRNA-21,IL-17 and HIF-1α in study group were significantly higher than those in control group,and the differences were statistically significant(P<0.01).The levels of miRNA-21,IL-17 and HIF-1α in multiple myeloma patients with poor prognosis were significantly higher than those in patients with good prognosis,and the differences were statistically significant(P<0.01).The level of miRNA-21 was positively correlated with IL-17 and HIF-1α levels in multiple myeloma patients(r=0.447,0.462,P<0.05).miRNA-21,IL-17 and HIF-1α were independent prognostic risk factors in multiple myeloma patients(P<0.05).ROC curve showed that the area under the curve(AUC),sensitivity,specificity,positive predictive value and negative pre-dictive value of miRNA-21,IL-17 and HIF-1α combined detection in the diagnosis of multiple myeloma were higher than those of the three single detection.The AUC,sensitivity,and negative predictive value of miRNA-21,IL-17 and HIF-1αcombined detection to predict the prognosis of multiple myeloma patients were higher than those of the three single detec-tion.The two-year cumulative survival rates of multiple myeloma patients in miRNA-21,IL-17 and HIF-1α high expres-sion group were lower than those in miRNA-21,IL-17 and HIF-1α low expression group,respectively,and the differences were statistically significant(P<0.05).Conclusion The levels of miRNA-21,IL-17 and HIF-1α in multiple myeloma pa-tients are highly expressed,and the level of miRNA-21 is positively correlated with IL-17 and HIF-1α levels.The com-bined detection of the three can better diagnose multiple myeloma and predict prognosis.It is helpful to take effective pre-vention and treatment measures and improve the prognosis of multiple myeloma patients.

multiple myelomamicroRNA-21interleukin-17hypoxia-inducible factor-1αcorrelationprognosisdiagnostic value

杨晓煜、朱登勤、庞素蕾、王盼盼、马若巾、马云云、宋春鸽

展开 >

郑州大学第五附属医院血液内科,郑州 450052

多发性骨髓瘤 miRNA-21 白细胞介素-17 缺氧诱导因子-1α 相关性 预后 诊断价值

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(2)
  • 1